Bioprinting

Rousselot and Gelomics to Create Ready-to-Use 3D Cell Culture Kits

Earlier this year, Rousselot Biomedical, a strategic segment established within Darling Ingredients (NYSE: DAR) in 2018, launched a cobranding program to pair its own expertise in biomedical gelatins with some…

Inventia Expands Bioprinting Facility in Australia With Government Support

Australian bioprinting startup Inventia Life Science is expanding its local footprint with support from the New South Wales (NSW) government. The Alexandria-based biotech company, a global leader in 3D cell…

3D Printing News Briefs, November 12, 2022: Composites, Bioprinted Breast Tumors, & More

Business, aerospace, bioprinting, and more are on the agenda for today’s 3D Printing News Briefs! APG adopted Tritone’s MoldJet Technology, Austal USA is overseeing an AM Center of Excellence in…

$1.3M Funds 100X Speed Volumetric 3D Printing from Vitro3D

Vitro3D, a spinout of the University of Colorado at Boulder and a part of The Colorado Life Science Incubation Program, has received $1.3M in a seed funding round, which will…

Featured

Bioprinting Industry Worth $1.2B by 2028, says SmarTech Report

After years of monitoring the bioprinting industry, a new SmarTech Analysis report estimates that this segment’s market size is expected to reach almost $1.2 billion in 2028, compared with just…

Inventia Life Science Opens its First U.S. Bioprinting Office in Delaware

Bioprinting machine manufacturer Inventia Life Science has opened its first U.S. office and facility at Delaware NGO The Innovation Space. The Sydney, Australia-based startup will benefit from the rich life…

Cardiac Patch to Be 3D Printed by Poietis and Stem Cell Pioneer Philippe Menasché

During the next three years, French bioprinting startup Poietis will work with renowned cardiothoracic surgeon Philippe Menasché to develop a functional clinical-grade cardiac patch to treat heart failure. The collaboration…

GMP-compliant Plant Receives Poietis Bioprinter for Tissue Fabrication Research

French biotech startup Poietis will install its high-resolution Next-Generation Bioprinting (NGB)-C robotic platform at a GMP (Good Manufacturing Practice)-compliant bioprinting plant located at the University of Barcelona (UB) ‘s Production…

3D Printing News Briefs, September 17, 2022: Autodesk Profiles, FDA Clearance & More

We’re starting with software in today’s 3D Printing News Briefs, as Autodesk has released 3D printing profiles for two of The Virtual Foundry’s filaments and Sigma Additive Solutions joined the…

New Bioinks Could Pave the Road for 3D Printed Medical Tattoos

A staff of researchers from Texas A&M University have created a new 3D printing bioink that leverages the conductivity of a novel nanomaterial and the biocompatibility of hydrogel. The bioprinting…

Featured

3D Systems Spins off Bioprinting Startup Systemic Bio

After venturing deeply into the bioprinting space, 3D Systems (NYSE: DDD) is shifting gears by spinning out its assets in this sector into a new, wholly owned company: Systemic Bio….

Featured

Bioprinting with 3D Systems’ Taci Pereira – AMS Focus

Though Additive Manufacturing Strategies (February 7-9, 2023) takes place just once a year, the verticals showcased at New York’s only 3D printing event are constantly evolving. The AMS Corner highlights…

Featured

First Native Woman to Lead NASA Mission Eager to Bioprint aboard ISS

NASA is preparing for SpaceX’s fifth astronaut mission to the International Space Station (ISS). Scheduled to launch this fall from NASA’s Kennedy Space Center in Florida, the Crew-5 mission will…

3D Printing News Briefs, August 20, 2022: Consumer 3D Printer, WAAM Study, & More

In today’s 3D Printing News Briefs, EPLUS3D is offering metal 3D printing as an option for flexible manufacturing of sheet metal. Anycubic is working with a MicroLED display manufacturer to…

With $35M Bioprinting Investment Prellis Biologics Takes on New CEO

Organ bioprinting startup Prellis Biologics raised $35 million in a Series C round and plans to use the fresh capital to expand its proprietary, first-in-class human immune system-based drug discovery…

ZEISS Invests in Precise Bio’s Bioprinted Tissue for Corneal Implants

Regenerative medicine startup Precise Bio and Carl Zeiss Meditec (ZEISS), a medical technology company, have begun a partnership for the purposes of developing and commercializing 3D bioprinted corneal tissue for…

3D Printing News Briefs, July 27, 2022: Standards, Software, & Research

In today’s 3D Printing News Briefs, a proposed standard from ASTM International would define filament properties. Mango 3D announced a major update for its Lychee slicer. Finally, on to research,…

Researchers at the University of Houston Are Optimistic About Bioelectronics

A June 16, 2022 edition of the materials science journal Advanced Materials includes a study, published by a team at the University of Houston, on 3D printed, micro-scale, organic electronics….

Featured

2022’s Bear Market Shake 3D Printing Stock Prices

After a ruthless start to 2022, the US’s three most widely followed indexes hit new lows as they entered the bear market terrain around mid-May. One month later, the Wall…

Featured

Brinter Bioprinter Now 3D Prints Pet-Friendly Pharmaceuticals

3D printed medications, while not yet mainstream, do exist, and the technology enables more personalized pharmaceuticals. A team of researchers from Åbo Akademi University in Finland are using the modular 3D…

Revisiting 3DPrint.com’s Bioprinting Zone: An Evolving Startup Landscape and World Map

Ever since 3DPrint.com created the Bioprinting Zone and published the first world map of bioprinting companies in June 2019, things have changed a bit. Not only did many businesses succumb…

Featured

3D Printed Human Lung Scaffold Showcased by 3D Systems and United Therapeutics

Ever since 3D Systems (NYSE: DDD) partnered with biotech firm United Therapeutics (Nasdaq: UTHR) in 2017, the duo have focused on printing scaffolds for human lungs. The hope is that…

Inventia Snags $3.2M in New Funding to Commercialize Bioprinter

After announcing a Series B round last January, Sydney-headquartered biotech startup Inventia received an additional AU$4.4 million ($3.2 million) from Australian pension fund giant HESTA. This latest investment brings Inventia’s…

Bioprinted Ear Transplants in Clinical Trials with 3DBio

Affecting one to five of every 100,000 children born, Microtia is a condition in which an individual has an undeveloped ear or no external ear features at all. Treatment may…